Login to your account

Username *
Password *
Remember Me
RCT: The effect of azithromycin on structural lung disease in infants with cystic fibrosis.

RCT: The effect of azithromycin on structural lung disease in infants with cystic fibrosis.

The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial – The Lancet Respiratory Medicine (link to abstract – $ for full-text)  

The post RCT: The effect of azithromycin on structural lung disease in infants with cystic fibrosis. appeared first on Links Medicus.

Lu 888 fois
Évaluer cet élément
(0 Votes)

About Author

Laissez un commentaire

Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.